Our vision is simple:
A future where the word ‘incurable’ no longer exists
scroll

At Graphite Bio, we’re working to achieve just that. We are driven by our passion to help patients live their best lives possible by rewriting genes so they can write the next chapter of their life story. We are reimagining what we can achieve through the science of gene editing to make ‘one dose, one cure’ a reality.

Cures start with you.

Aiming to fulfill the promise of cures

We are harnessing the power of connections—within the body to heal, to those who are seeking cures, within our own organization, and to others who share our mission—in pursuit of cures for genetic diseases.

See what sets us apart

Realizing the full potential of gene editing

Our UltraHDR™ platform is driving the future of gene editing forward, building on CRISPR technology to precisely correct, replace, and insert genes anywhere in the genome.

Discover our science

Pursuing cures to give hope to millions

We strive to develop therapies for some of the most serious genetic diseases, rewriting DNA so that patients can write the next chapter of their life story.

See what we’re developing

A company connected by passion and purpose

Our team of big thinkers uses bold ideas and a collaborative culture to bring out the best in each other as we pursue cures for seemingly incurable diseases.

Work with us

Graphite Bio Announces Voluntary Pause of Phase 1/2 CEDAR Study of nulabeglogene autogedtemcel (nula-cel) for Sickle Cell Disease

Jan 5th, 2023

Graphite Bio Presents Preclinical Data for Novel Sequencing Method Used to Determine Gene Editing Outcomes at 64th ASH Annual Meeting

Dec 11th, 2022

Graphite Bio Announces Participation in Evercore ISI 5th Annual HealthCONx Conference

Nov 21st, 2022
All news